press release
MATTER, the Merch Mart-based hub for healthcare innovation, announced that it’s collaborating withAbbott, the global drug and research giant, “to accelerate the development of new technologies that improve health and healthcare.” Together, they’ll identify promising, emerging technologies that are potential candidates for commercialization. Abbott will also join MATTER as a mentor to the hub’…
Read more
matter news
MATTER, the healthcare technology incubator, today announced a collaboration with Abbott, the global healthcare company, to support healthcare innovation. The two companies will work together to accelerate the development of new technologies that improve health and healthcare. Abbott joins as one of eight platinum-level partners from across the healthcare industry.
Abbott will work with MATTER…
Read more
matter news
Abbott, one of Chicago’s biggest healthcare companies, has signed on as a top-level partner of Matter, the health-technology incubator at the Merchandise Mart.
Abbott is a platinum-level sponsor, alongside seven other healthcare heavyweights, such as AbbVie, Astellas, Blue Cross & Blue Shield of Illinois, Takeda and others.
“It’s one of the biggest healthcare brand names in Chicago,” sa…
Read more
press release
!
U.S. Representative Robin Kelly (D-IL) today visited healthcare technology incubator MATTER to discuss healthcare innovation with early-stage entrepreneurs and industry leaders.
Launched in February 2015, MATTER is a community of health technology startups and industry leaders from across the ecosystem that are working together to foster innovation in health IT, medical devices, diagnostics…
Read more
tales from the trenches
Jeff Aronin, CEO of Paragon Biosciences, was a featured guest in MATTER’sTales from the Trenchesseries. Paragon focuses on identifying unmet medical needs, novel science, and then builds companies with world-class talent to bring medications to market. He and ContextMedia CEO Rishi Shah discussed how he got into healthcare; his work, management, and investment style; and pharmaceutical industry…
Read more